APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fibromyalgia Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fibromyalgia Therapeutics Drugs Market Analysis and Forecast 2026-2032

Report ID 173991760231 December 2025200 pages

Choose your research edition.

Industry ResearchFibromyalgia Therapeutics Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Fibromyalgia Therapeutics Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Fibromyalgia Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fibromyalgia Therapeutics Drugs Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Fibromyalgia Therapeutics Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Fibromyalgia Therapeutics Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Fibromyalgia Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fibromyalgia Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fibromyalgia Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fibromyalgia Therapeutics Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Fibromyalgia Therapeutics Drugs include Eli Lilly, Pfizer, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Theravance, Switch Biotech, Pierre Fabre Mdicament, Merck Sharp and Dohme and Meiji Seika, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Fibromyalgia Therapeutics Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fibromyalgia Therapeutics Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Fibromyalgia Therapeutics Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fibromyalgia Therapeutics Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fibromyalgia Therapeutics Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fibromyalgia Therapeutics Drugs sales, projected growth trends, production technology, application and end-user industry.

Fibromyalgia Therapeutics Drugs Segment by Company

Eli Lilly

Pfizer

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Theravance

Switch Biotech

Pierre Fabre Mdicament

Merck Sharp and Dohme

Meiji Seika

Meda

Innovative Med Concepts

Forest Pharmaceuticals, Inc.

Daiichi Sankyo

Daiichi Sankyo

Boehringer Ingelheim GmbH

Actavis

Fibromyalgia Therapeutics Drugs Segment by Type

Cymbalta (Duloxetine)

Savella (Milnacipran)

Lyrica (Pregabalin)

Pancuronium

Others

Fibromyalgia Therapeutics Drugs Segment by Application

Hospital

Clinic

Others

Fibromyalgia Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibromyalgia Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fibromyalgia Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibromyalgia Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Fibromyalgia Therapeutics Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Fibromyalgia Therapeutics Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fibromyalgia Therapeutics Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cymbalta (Duloxetine) Major Manufacturers Table 3. Savella (Milnacipran) Major Manufacturers Table 4. Lyrica (Pregabalin) Major Manufacturers Table 5. Pancuronium Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Fibromyalgia Therapeutics Drugs Industry Trends Table 12. Fibromyalgia Therapeutics Drugs Industry Drivers Table 13. Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges Table 14. Fibromyalgia Therapeutics Drugs Industry Restraints Table 15. Global Fibromyalgia Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Fibromyalgia Therapeutics Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 21. Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026) & (Kg) Table 22. Global Fibromyalgia Therapeutics Drugs Sales by Region (2027-2032) & (Kg) Table 23. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 24. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2027-2032) Table 25. Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Fibromyalgia Therapeutics Drugs Sales Price (US$/g) of Manufacturers (2021-2026) Table 30. Global Fibromyalgia Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Fibromyalgia Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Fibromyalgia Therapeutics Drugs Manufacturers, Product Type & Application Table 33. Global Fibromyalgia Therapeutics Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Fibromyalgia Therapeutics Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Fibromyalgia Therapeutics Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Fibromyalgia Therapeutics Drugs Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 42. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 43. Global Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 44. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2026) Table 45. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2027-2032) Table 46. Global Fibromyalgia Therapeutics Drugs Price by Type (2021-2026) & (US$/g) Table 47. Global Fibromyalgia Therapeutics Drugs Price by Type (2027-2032) & (US$/g) Table 48. Global Fibromyalgia Therapeutics Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Fibromyalgia Therapeutics Drugs Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 54. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 55. Global Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 56. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2026) Table 57. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2027-2032) Table 58. Global Fibromyalgia Therapeutics Drugs Price by Application (2021-2026) & (US$/g) Table 59. Global Fibromyalgia Therapeutics Drugs Price by Application (2027-2032) & (US$/g) Table 60. Eli Lilly Company Information Table 61. Eli Lilly Business Overview Table 62. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 63. Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio Table 64. Eli Lilly Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio Table 69. Pfizer Recent Development Table 70. Zynerba Pharmaceuticals Company Information Table 71. Zynerba Pharmaceuticals Business Overview Table 72. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio Table 74. Zynerba Pharmaceuticals Recent Development Table 75. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information Table 76. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview Table 77. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio Table 79. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development Table 80. Theravance Company Information Table 81. Theravance Business Overview Table 82. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Theravance Fibromyalgia Therapeutics Drugs Product Portfolio Table 84. Theravance Recent Development Table 85. Switch Biotech Company Information Table 86. Switch Biotech Business Overview Table 87. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio Table 89. Switch Biotech Recent Development Table 90. Pierre Fabre Mdicament Company Information Table 91. Pierre Fabre Mdicament Business Overview Table 92. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio Table 94. Pierre Fabre Mdicament Recent Development Table 95. Merck Sharp and Dohme Company Information Table 96. Merck Sharp and Dohme Business Overview Table 97. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio Table 99. Merck Sharp and Dohme Recent Development Table 100. Meiji Seika Company Information Table 101. Meiji Seika Business Overview Table 102. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 103. Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio Table 104. Meiji Seika Recent Development Table 105. Meda Company Information Table 106. Meda Business Overview Table 107. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 108. Meda Fibromyalgia Therapeutics Drugs Product Portfolio Table 109. Meda Recent Development Table 110. Innovative Med Concepts Company Information Table 111. Innovative Med Concepts Business Overview Table 112. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 113. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio Table 114. Innovative Med Concepts Recent Development Table 115. Forest Pharmaceuticals, Inc. Company Information Table 116. Forest Pharmaceuticals, Inc. Business Overview Table 117. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 118. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio Table 119. Forest Pharmaceuticals, Inc. Recent Development Table 120. Daiichi Sankyo Company Information Table 121. Daiichi Sankyo Business Overview Table 122. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 123. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 124. Daiichi Sankyo Recent Development Table 125. Daiichi Sankyo Company Information Table 126. Daiichi Sankyo Business Overview Table 127. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 128. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio Table 129. Daiichi Sankyo Recent Development Table 130. Boehringer Ingelheim GmbH Company Information Table 131. Boehringer Ingelheim GmbH Business Overview Table 132. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 133. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio Table 134. Boehringer Ingelheim GmbH Recent Development Table 135. Actavis Company Information Table 136. Actavis Business Overview Table 137. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 138. Actavis Fibromyalgia Therapeutics Drugs Product Portfolio Table 139. Actavis Recent Development Table 140. North America Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 143. North America Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 144. North America Fibromyalgia Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/g) Table 145. North America Fibromyalgia Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/g) Table 146. North America Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. North America Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. North America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 149. North America Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 150. North America Fibromyalgia Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/g) Table 151. North America Fibromyalgia Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/g) Table 152. North America Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. North America Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. North America Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. North America Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 156. North America Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 157. North America Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 158. North America Fibromyalgia Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/g) Table 159. North America Fibromyalgia Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/g) Table 160. United States Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 161. Canada Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 162. Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 165. Europe Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 166. Europe Fibromyalgia Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/g) Table 167. Europe Fibromyalgia Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/g) Table 168. Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 169. Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 170. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 171. Europe Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 172. Europe Fibromyalgia Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/g) Table 173. Europe Fibromyalgia Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/g) Table 174. Europe Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Europe Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Europe Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 178. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 179. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 180. Europe Fibromyalgia Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/g) Table 181. Europe Fibromyalgia Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/g) Table 182. Germany Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 183. France Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 184. U.K. Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 185. Italy Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 187. China Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 188. China Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 189. China Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 190. China Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 191. China Fibromyalgia Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/g) Table 192. China Fibromyalgia Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/g) Table 193. China Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 194. China Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 195. China Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 196. China Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 197. China Fibromyalgia Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/g) Table 198. China Fibromyalgia Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/g) Table 199. Asia Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 200. Asia Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 201. Asia Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 202. Asia Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 203. Asia Fibromyalgia Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/g) Table 204. Asia Fibromyalgia Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/g) Table 205. Asia Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 206. Asia Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 207. Asia Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 208. Asia Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 209. Asia Fibromyalgia Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/g) Table 210. Asia Fibromyalgia Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/g) Table 211. Asia Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Asia Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. Asia Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. Asia Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 215. Asia Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 216. Asia Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 217. Asia Fibromyalgia Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/g) Table 218. Asia Fibromyalgia Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/g) Table 219. Japan Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 220. South Korea Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 221. India Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 222. Australia Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 223. China Taiwan Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 224. Southeast Asia Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 225. SAMEA Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2026) & (US$ Million) Table 226. SAMEA Fibromyalgia Therapeutics Drugs Revenue by Type (2027-2032) & (US$ Million) Table 227. SAMEA Fibromyalgia Therapeutics Drugs Sales by Type (2021-2026) & (Kg) Table 228. SAMEA Fibromyalgia Therapeutics Drugs Sales by Type (2027-2032) & (Kg) Table 229. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Type (2021-2026) & (US$/g) Table 230. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Type (2027-2032) & (US$/g) Table 231. SAMEA Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2026) & (US$ Million) Table 232. SAMEA Fibromyalgia Therapeutics Drugs Revenue by Application (2027-2032) & (US$ Million) Table 233. SAMEA Fibromyalgia Therapeutics Drugs Sales by Application (2021-2026) & (Kg) Table 234. SAMEA Fibromyalgia Therapeutics Drugs Sales by Application (2027-2032) & (Kg) Table 235. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Application (2021-2026) & (US$/g) Table 236. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Application (2027-2032) & (US$/g) Table 237. SAMEA Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. SAMEA Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 239. SAMEA Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 240. SAMEA Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 241. SAMEA Fibromyalgia Therapeutics Drugs Sales by Country (2021-2026) & (Kg) Table 242. SAMEA Fibromyalgia Therapeutics Drugs Sales by Country (2027-2032) & (Kg) Table 243. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Country (2021-2026) & (US$/g) Table 244. SAMEA Fibromyalgia Therapeutics Drugs Sales Price by Country (2027-2032) & (US$/g) Table 245. Brazil Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 246. Argentina Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 247. Chile Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 248. Colombia Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 249. Peru Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 250. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 251. Israel Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 252. UAE Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 253. Turkey Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 254. Iran Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 255. Egypt Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Table 256. Key Raw Materials Table 257. Raw Materials Key Suppliers Table 258. Fibromyalgia Therapeutics Drugs Distributors List Table 259. Fibromyalgia Therapeutics Drugs Customers List Table 260. Research Programs/Design for This Report Table 261. Authors List of This Report Table 262. Secondary Sources Table 263. Primary Sources List of Figures Figure 1. Fibromyalgia Therapeutics Drugs Image Figure 2. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fibromyalgia Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cymbalta (Duloxetine) Image Figure 5. Savella (Milnacipran) Image Figure 6. Lyrica (Pregabalin) Image Figure 7. Pancuronium Image Figure 8. Others Image Figure 9. Global Fibromyalgia Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Fibromyalgia Therapeutics Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Fibromyalgia Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Fibromyalgia Therapeutics Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Fibromyalgia Therapeutics Drugs Sales (2021-2032) & (Kg) Figure 20. Global Fibromyalgia Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 21. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Fibromyalgia Therapeutics Drugs Sales YoY (2021-2032) & (Kg) Figure 23. Europe Fibromyalgia Therapeutics Drugs Sales YoY (2021-2032) & (Kg) Figure 24. China Fibromyalgia Therapeutics Drugs Sales YoY (2021-2032) & (Kg) Figure 25. Asia (Excluding China) Fibromyalgia Therapeutics Drugs Sales YoY (2021-2032) & (Kg) Figure 26. South America, Middle East and Africa Fibromyalgia Therapeutics Drugs Sales YoY (2021-2032) & (Kg) Figure 27. Global Fibromyalgia Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Fibromyalgia Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Fibromyalgia Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 34. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Fibromyalgia Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 40. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Fibromyalgia Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 43. North America Fibromyalgia Therapeutics Drugs Sales Share by Type (2021-2032) Figure 44. North America Fibromyalgia Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 45. North America Fibromyalgia Therapeutics Drugs Sales Share by Application (2021-2032) Figure 46. North America Fibromyalgia Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 47. North America Fibromyalgia Therapeutics Drugs Sales Share by Country (2021-2032) Figure 48. Europe Fibromyalgia Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Fibromyalgia Therapeutics Drugs Sales Share by Type (2021-2032) Figure 50. Europe Fibromyalgia Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Fibromyalgia Therapeutics Drugs Sales Share by Application (2021-2032) Figure 52. Europe Fibromyalgia Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Fibromyalgia Therapeutics Drugs Sales Share by Country (2021-2032) Figure 54. China Fibromyalgia Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 55. China Fibromyalgia Therapeutics Drugs Sales Share by Type (2021-2032) Figure 56. China Fibromyalgia Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 57. China Fibromyalgia Therapeutics Drugs Sales Share by Application (2021-2032) Figure 58. Asia Fibromyalgia Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Fibromyalgia Therapeutics Drugs Sales Share by Type (2021-2032) Figure 60. Asia Fibromyalgia Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Fibromyalgia Therapeutics Drugs Sales Share by Application (2021-2032) Figure 62. Asia Fibromyalgia Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Fibromyalgia Therapeutics Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Fibromyalgia Therapeutics Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Fibromyalgia Therapeutics Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Fibromyalgia Therapeutics Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Fibromyalgia Therapeutics Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Fibromyalgia Therapeutics Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Fibromyalgia Therapeutics Drugs Sales Share by Country (2021-2032) Figure 70. Fibromyalgia Therapeutics Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Fibromyalgia Therapeutics Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Cymbalta (Duloxetine)
  • Savella (Milnacipran)
  • Lyrica (Pregabalin)
  • Pancuronium
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Eli Lilly
  • Pfizer
  • Zynerba Pharmaceuticals
  • Tonix Pharmaceuticals Holding Corp. (TNXP)
  • Theravance
  • Switch Biotech
  • Pierre Fabre Mdicament
  • Merck Sharp and Dohme
  • Meiji Seika
  • Meda
  • Innovative Med Concepts
  • Forest Pharmaceuticals, Inc.
  • Daiichi Sankyo
  • Daiichi Sankyo
  • Boehringer Ingelheim GmbH
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fibromyalgia Therapeutics Drugs Market by Type
  3. 1.2.1 Global Fibromyalgia Therapeutics Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cymbalta (Duloxetine)
  5. 1.2.3 Savella (Milnacipran)
  6. 1.2.4 Lyrica (Pregabalin)
  7. 1.2.5 Pancuronium
  8. 1.2.6 Others
  9. 1.3 Fibromyalgia Therapeutics Drugs Market by Application
  10. 1.3.1 Global Fibromyalgia Therapeutics Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Fibromyalgia Therapeutics Drugs Market Dynamics
  1. 2.1 Fibromyalgia Therapeutics Drugs Industry Trends
  2. 2.2 Fibromyalgia Therapeutics Drugs Industry Drivers
  3. 2.3 Fibromyalgia Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Fibromyalgia Therapeutics Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Fibromyalgia Therapeutics Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region
  3. 3.2.1 Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Fibromyalgia Therapeutics Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Fibromyalgia Therapeutics Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Fibromyalgia Therapeutics Drugs Sales by Region
  9. 3.4.1 Global Fibromyalgia Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Fibromyalgia Therapeutics Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Fibromyalgia Therapeutics Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers
  2. 4.1.1 Global Fibromyalgia Therapeutics Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Fibromyalgia Therapeutics Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers
  6. 4.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Fibromyalgia Therapeutics Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Fibromyalgia Therapeutics Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Fibromyalgia Therapeutics Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Fibromyalgia Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Fibromyalgia Therapeutics Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Fibromyalgia Therapeutics Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Fibromyalgia Therapeutics Drugs Market CR5 and HHI
  16. 4.8.2 2025 Fibromyalgia Therapeutics Drugs Tier 1, Tier 2, and Tier 3
5 Fibromyalgia Therapeutics Drugs Market by Type
  1. 5.1 Global Fibromyalgia Therapeutics Drugs Revenue by Type
  2. 5.1.1 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Fibromyalgia Therapeutics Drugs Sales by Type
  6. 5.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Fibromyalgia Therapeutics Drugs Price by Type
6 Fibromyalgia Therapeutics Drugs Market by Application
  1. 6.1 Global Fibromyalgia Therapeutics Drugs Revenue by Application
  2. 6.1.1 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Fibromyalgia Therapeutics Drugs Sales by Application
  6. 6.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Fibromyalgia Therapeutics Drugs Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly
  2. 7.1.1 Eli Lilly Company Information
  3. 7.1.2 Eli Lilly Business Overview
  4. 7.1.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio
  6. 7.1.5 Eli Lilly Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Zynerba Pharmaceuticals
  14. 7.3.1 Zynerba Pharmaceuticals Company Information
  15. 7.3.2 Zynerba Pharmaceuticals Business Overview
  16. 7.3.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio
  18. 7.3.5 Zynerba Pharmaceuticals Recent Developments
  19. 7.4 Tonix Pharmaceuticals Holding Corp. (TNXP)
  20. 7.4.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Information
  21. 7.4.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
  22. 7.4.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio
  24. 7.4.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments
  25. 7.5 Theravance
  26. 7.5.1 Theravance Company Information
  27. 7.5.2 Theravance Business Overview
  28. 7.5.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Theravance Fibromyalgia Therapeutics Drugs Product Portfolio
  30. 7.5.5 Theravance Recent Developments
  31. 7.6 Switch Biotech
  32. 7.6.1 Switch Biotech Company Information
  33. 7.6.2 Switch Biotech Business Overview
  34. 7.6.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio
  36. 7.6.5 Switch Biotech Recent Developments
  37. 7.7 Pierre Fabre Mdicament
  38. 7.7.1 Pierre Fabre Mdicament Company Information
  39. 7.7.2 Pierre Fabre Mdicament Business Overview
  40. 7.7.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio
  42. 7.7.5 Pierre Fabre Mdicament Recent Developments
  43. 7.8 Merck Sharp and Dohme
  44. 7.8.1 Merck Sharp and Dohme Company Information
  45. 7.8.2 Merck Sharp and Dohme Business Overview
  46. 7.8.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio
  48. 7.8.5 Merck Sharp and Dohme Recent Developments
  49. 7.9 Meiji Seika
  50. 7.9.1 Meiji Seika Company Information
  51. 7.9.2 Meiji Seika Business Overview
  52. 7.9.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio
  54. 7.9.5 Meiji Seika Recent Developments
  55. 7.10 Meda
  56. 7.10.1 Meda Company Information
  57. 7.10.2 Meda Business Overview
  58. 7.10.3 Meda Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Meda Fibromyalgia Therapeutics Drugs Product Portfolio
  60. 7.10.5 Meda Recent Developments
  61. 7.11 Innovative Med Concepts
  62. 7.11.1 Innovative Med Concepts Company Information
  63. 7.11.2 Innovative Med Concepts Business Overview
  64. 7.11.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio
  66. 7.11.5 Innovative Med Concepts Recent Developments
  67. 7.12 Forest Pharmaceuticals, Inc.
  68. 7.12.1 Forest Pharmaceuticals, Inc. Company Information
  69. 7.12.2 Forest Pharmaceuticals, Inc. Business Overview
  70. 7.12.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio
  72. 7.12.5 Forest Pharmaceuticals, Inc. Recent Developments
  73. 7.13 Daiichi Sankyo
  74. 7.13.1 Daiichi Sankyo Company Information
  75. 7.13.2 Daiichi Sankyo Business Overview
  76. 7.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  78. 7.13.5 Daiichi Sankyo Recent Developments
  79. 7.14 Daiichi Sankyo
  80. 7.14.1 Daiichi Sankyo Company Information
  81. 7.14.2 Daiichi Sankyo Business Overview
  82. 7.14.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
  84. 7.14.5 Daiichi Sankyo Recent Developments
  85. 7.15 Boehringer Ingelheim GmbH
  86. 7.15.1 Boehringer Ingelheim GmbH Company Information
  87. 7.15.2 Boehringer Ingelheim GmbH Business Overview
  88. 7.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio
  90. 7.15.5 Boehringer Ingelheim GmbH Recent Developments
  91. 7.16 Actavis
  92. 7.16.1 Actavis Company Information
  93. 7.16.2 Actavis Business Overview
  94. 7.16.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Actavis Fibromyalgia Therapeutics Drugs Product Portfolio
  96. 7.16.5 Actavis Recent Developments
8 North America
  1. 8.1 North America Fibromyalgia Therapeutics Drugs Market Size by Type
  2. 8.1.1 North America Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Fibromyalgia Therapeutics Drugs Price by Type (2021-2032)
  5. 8.2 North America Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 8.2.1 North America Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Fibromyalgia Therapeutics Drugs Price by Application (2021-2032)
  9. 8.3 North America Fibromyalgia Therapeutics Drugs Market Size by Country
  10. 8.3.1 North America Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Fibromyalgia Therapeutics Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Fibromyalgia Therapeutics Drugs Market Size by Type
  2. 9.1.1 Europe Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Fibromyalgia Therapeutics Drugs Price by Type (2021-2032)
  5. 9.2 Europe Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 9.2.1 Europe Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Fibromyalgia Therapeutics Drugs Price by Application (2021-2032)
  9. 9.3 Europe Fibromyalgia Therapeutics Drugs Market Size by Country
  10. 9.3.1 Europe Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Fibromyalgia Therapeutics Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Fibromyalgia Therapeutics Drugs Market Size by Type
  2. 10.1.1 China Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Fibromyalgia Therapeutics Drugs Price by Type (2021-2032)
  5. 10.2 China Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 10.2.1 China Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Fibromyalgia Therapeutics Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fibromyalgia Therapeutics Drugs Market Size by Type
  2. 11.1.1 Asia Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Fibromyalgia Therapeutics Drugs Price by Type (2021-2032)
  5. 11.2 Asia Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 11.2.1 Asia Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Fibromyalgia Therapeutics Drugs Price by Application (2021-2032)
  9. 11.3 Asia Fibromyalgia Therapeutics Drugs Market Size by Country
  10. 11.3.1 Asia Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Fibromyalgia Therapeutics Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fibromyalgia Therapeutics Drugs Market Size by Type
  2. 12.1.1 SAMEA Fibromyalgia Therapeutics Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Fibromyalgia Therapeutics Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Fibromyalgia Therapeutics Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Fibromyalgia Therapeutics Drugs Market Size by Application
  6. 12.2.1 SAMEA Fibromyalgia Therapeutics Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Fibromyalgia Therapeutics Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Fibromyalgia Therapeutics Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Fibromyalgia Therapeutics Drugs Market Size by Country
  10. 12.3.1 SAMEA Fibromyalgia Therapeutics Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Fibromyalgia Therapeutics Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Fibromyalgia Therapeutics Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Fibromyalgia Therapeutics Drugs Value Chain Analysis
  2. 13.1.1 Fibromyalgia Therapeutics Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Fibromyalgia Therapeutics Drugs Production Mode & Process
  6. 13.2 Fibromyalgia Therapeutics Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Fibromyalgia Therapeutics Drugs Distributors
  9. 13.2.3 Fibromyalgia Therapeutics Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst